Trials / Completed
CompletedNCT00247819
The Genetic Basis for Vulnerability to Substance Abuse
Allelic Linkage in Substance Abuse
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,000 (estimated)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This investigation seeks to better define the genetic basis for vulnerability to substance abuse.
Detailed description
Dopamine (DA), a neurotransmitter helping to mediate reward and reinforcement, has been putatively linked to the development of substance abuse, alcohol abuse, and alcoholism. Identification of specific vulnerability-association alleles for receptors, other molecules within the reward mediating system, and other genes that may predispose individuals to the development of such disorders is the goal of the study. This investigation will help elucidate the genetic underpinnings of substance abuse, potentially leading to the improved methods to diagnose those at risk and to help develop better therapeutic interventions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood draw |
Timeline
- Start date
- 1992-08-01
- Primary completion
- 2006-02-01
- Completion
- 2006-02-01
- First posted
- 2005-11-02
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00247819. Inclusion in this directory is not an endorsement.